Pützer BM, Rödicker F.
The Power of Interleukin-12/B7.1 Immunotherapy: A Rationale for Non Imunogenic Pancreatic Cancer Treatment.
Ed. Maxwell A. Loft: Focus on Pancreatic Cancer; Nova Medical Books, Nova Science Publishers, Inc., 2004.
Vorheriger Beitrag
Tumor targeting.
Nächster Beitrag
The RET proto-oncogene: A valuable target for thyroid cancer therapy.